| Source NDC Code |
|
Target HCPCS Code |
55135-0132-01
TRODELVY 180 MG VIAL
|
⇄
|
C9066
IJ, sacituzumab govitecan-hziy, 2.5 mg
|
| Detail Information |
| Relationship Start Date |
10/01/2020 |
| Relationship End Date |
12/31/2020 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
55135-0132-01
TRODELVY (PF,LYOPHILIZED) 180 MG
|
⇄
|
J9317
INJECTION, SACITUZUMAB GOVITECAN-HZIY, 2.5 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
55135-0132-01
TRODELVY 180 MG VIAL
|
⇄
|
J9999
NOT OTHERWISE CLASSIFIED, ANTINEOPLASTIC DRUGS
|
| Detail Information |
| Relationship Start Date |
10/01/2020 |
| Relationship End Date |
12/31/2020 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
55135-0132-01
TRODELVY
|
⇄
|
J9317
Sacituzumab govitecan-hziy
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|